C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2004
12/23/2004	US20040258677 Suppressing immune response; providing tolerance to amino acid sequences different than host
12/23/2004	US20040258664 Inducing phagocytosis; treating cow mastitis without leaving drugs in milk or producing drug-resistant bacterial strains; fish furunculosis
12/23/2004	US20040258660 Tumor necrosis factor alpha analogues having three dimensional structure of similar to proteins from which they are derived; facilitating correct folding
12/23/2004	US20040258616 Compositions and methods for treating cancer using IGSF9 and LIV-1
12/23/2004	DE10325639A1 Determining particular conditions or alterations in the uterine mucosa, useful e.g. for assessing receptivity for implantation, by measuring concentration of specific forms of human chorionogonadotrophin
12/23/2004	DE10325638A1 Determining particular conditions or alterations in the uterine mucosa, useful e.g. for assessing receptivity for implantation, by measuring concentration of specific forms of human chorionogonadotrophin
12/23/2004	CA2570398A1 Assessment of skeletal growth using measurements of nt-cnp peptides
12/23/2004	CA2529583A1 Oxidoreductase from pichia capsulata
12/23/2004	CA2529496A1 Anti-cd74 immunoconjugates and methods
12/23/2004	CA2528844A1 Novel phosphorylated sequences of the phosphatase cdc25b, antibodies for said sequences and use thereof
12/23/2004	CA2528418A1 Method to increase protein production in culture
12/23/2004	CA2527863A1 Cell surface protein associated with human chronic lymphocytic leukemia
12/23/2004	CA2527843A1 Immunotherapeutics for biodefense
12/23/2004	CA2527735A1 Functionally reconstituted viral membranes containing adjuvant
12/23/2004	CA2527621A1 Method of inhibiting tumor growth with anti-tissue factor antibodies
12/23/2004	CA2525917A1 Compositions and methods including a recombinant human mab that promotes cns remyelination
12/23/2004	CA2525517A1 Use of prion conversion modulating agents
12/23/2004	CA2524325A1 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
12/22/2004	EP1489188A1 Reaction solution for cell-free protein synthesis, method of preparing the same and protein synthesis method using the same
12/22/2004	EP1489183A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
12/22/2004	EP1489170A1 Transporter selectively transporting sulfate conjugate and its gene
12/22/2004	EP1489165A1 Recombinant fowlpox vaccine for protection against marek's disease
12/22/2004	EP1489164A1 Recombinant vaccinia viruses with modified F3 genes, uses thereof
12/22/2004	EP1489100A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/22/2004	EP1489099A2 Antibodies that bind the CD40CR receptor
12/22/2004	EP1489098A1 Production of hybridoma producing antihuman cenp-a peptide monoclonal antibody and method of using the same
12/22/2004	EP1489095A1 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
12/22/2004	EP1488806A2 A blocking monoclonal antibody to VLA-1 and its use for the treatment of vascular disorders
12/22/2004	EP1488805A2 CD28 pathway immunoregulation
12/22/2004	EP1488804A1 Immunoglobulin/hydrophilic peptide complexes
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488240A2 Detection of specific nitrated markers
12/22/2004	EP1488231A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
12/22/2004	EP1487991A2 Cancer-linked gene as target for chemotherapy
12/22/2004	EP1487972A2 Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use
12/22/2004	EP1487967A2 Chimeric pancreas
12/22/2004	EP1487879A2 Bispecific antibody point mutations for enhancing rate of clearance
12/22/2004	EP1487878A2 Anti-hpv-16 e7 antibodies and their use
12/22/2004	EP1487877A2 Compositions and methods for the diagnosis and treatment of tumor
12/22/2004	EP1487876A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/22/2004	EP1487875A2 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
12/22/2004	EP1487865A2 USES OF MAMMALIAN CYTOKINEi; RELATED REAGENTS
12/22/2004	EP1487857A1 Lymphatic and blood endothelial cell genes
12/22/2004	EP1487856A2 Human antibodies specific to kdr and uses thereof
12/22/2004	EP1487854A2 Novel isoforms of vascular endothelial ell growth inhibitor
12/22/2004	EP1487852A1 Anti-protozoal vaccine
12/22/2004	EP1487493A2 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
12/22/2004	EP1487492A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
12/22/2004	EP1487491A2 Novel of cytokine inhibitors
12/22/2004	EP1487490A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487488A1 Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
12/22/2004	EP1487487A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
12/22/2004	EP1487480A2 Fusion molecules and methods for treatment of immune diseases
12/22/2004	EP1487428A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/22/2004	EP1487260A2 The functional disruption of avian immunoglobulin genes
12/22/2004	EP1392866A4 Novel method for cloning variable domain sequences of immunological gene repertoire
12/22/2004	EP0862584B1 Production of antibodies
12/22/2004	EP0817648B1 Vascular endothelial cell growth factor antagonists
12/22/2004	EP0815236B1 Haemophilus adhesion proteins
12/22/2004	EP0658200B1 Glucagon receptors
12/22/2004	EP0598717B2 Duplex printer
12/22/2004	CN1556857A Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
12/22/2004	CN1556856A Vaccines from infectious agents
12/22/2004	CN1556854A Activation and expansion of cells
12/22/2004	CN1556815A Iron regulating protein-2 (IRP-2) as a diagnostic for neurodegenerative disease
12/22/2004	CN1556204A Anti prourokinase monoclonal antibody hybrid oma cell line and its application
12/22/2004	CN1556113A Yolk antibody of anti SARS coronavirus and its preparation method and liquid preparation
12/22/2004	CN1181201C LAG-3 splice variants
12/22/2004	CN1181098C Monoclonal antibody to alpha 2-macroglobulin and its use for detecting glucan
12/22/2004	CN1181097C Monochain antibody with dual specificities possessing activity for restraining adherence and aggregation of blood platelets
12/21/2004	US6833493 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
12/21/2004	US6833441 Compositions and methods for generating chimeric heteromultimers
12/21/2004	US6833438 Involves STEAP (six transmembrane epithelial antigen of the prostate); used in diagnosis, therapy and management of various cancers, including prostate cancer, colon cancer, bladder cancer, ovarian cancer and pancreatic cancer
12/21/2004	US6833268 Produced in response to immunization with any desired antigen
12/21/2004	US6833133 Escape mutants of Newcastle disease virus as marker vaccines
12/21/2004	US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity
12/21/2004	US6833131 Antivenom immunesera
12/21/2004	CA2386066C Detection of hla-g
12/16/2004	WO2004109840A1 Electrode, method of forming the same, photoelectric conversion device, process for producing the same, electronic apparatus and process for producing the same
12/16/2004	WO2004109292A2 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs
12/16/2004	WO2004109289A1 Method of diagnosing sars corona virus infection
12/16/2004	WO2004109286A2 Methods for detecting and treating cancer using podocalyxin and/or endoglycan
12/16/2004	WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody
12/16/2004	WO2004108909A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf
12/16/2004	WO2004108895A2 Humanized antibodies that recognize beta amyloid peptide
12/16/2004	WO2004108889A2 Hybrid antibodies
12/16/2004	WO2004108888A2 Micropositioning cells for tissue engineering
12/16/2004	WO2004108885A2 Fc chimeric proteins with anti-hiv drugs
12/16/2004	WO2004108766A2 Anti-hgf-r antibodies and their use
12/16/2004	WO2004108765A2 Extracellular aspergillus polypeptides
12/16/2004	WO2004108764A2 Connective tissue growth factor antibodies
12/16/2004	WO2004108756A2 Sars coronavirus peptides and uses thereof
12/16/2004	WO2004108748A2 Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses
12/16/2004	WO2004108159A2 Gb virus c (hepatitis g virus) for the treatment of hiv
12/16/2004	WO2004108158A1 De-immunized anti-cd3 antibody
12/16/2004	WO2004108157A2 Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders
12/16/2004	WO2004108078A2 Rationally designed antibodies
12/16/2004	WO2004108065A2 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
12/16/2004	WO2004094459A3 Polypeptides related to natriuretic peptides and methods of their identification and use

1 ... 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 ... 1494